Atorvastatin Calcium
Product Images NDC 70934-615
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatin-fig-1 (Atorvastatin Fig 1)
Atorvastatin-fig-2 (Atorvastatin Fig 2)
This text displays a chart or graph showing the cumulative hazard percentage over a 4-year follow-up period for a placebo group and a group treated with Atorvastatin. The graph indicates that Atorvastatin is associated with a lower risk of experiencing the primary endpoint compared to the placebo group.*
Atorvastatin-fig-3 (Atorvastatin Fig 3)
This text provides data on the percentage of subjects experiencing an event after taking different doses of atorvastatin for a certain period of time. The data shows that at a dose of 10 mg, no one experienced an event, while at a dose of 80 mg, the event rate was lowered by 22% compared to a placebo (P=0.0002). The chart shows the time to the first major cardiovascular endpoint in years.*
Atorvastatin-st (Atorvastatin St)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.